Financial News

Financial Report: Abbvie

HUMIRA sales were up 11% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Abbvie 3Q Revenues: $6.4 billion (+8%) 3Q Earnings: $1.6 billion (+29%) YTD Revenues: $11.8 billion (+7%) YTD Earnings: $4.6 billion (+26%) Comments: Global HUMIRA sales were up 11% to $4.1 billion in the quarter. IMBRUVICA sales were $501 million, up 65%.  Viekira sales were down 20% to $378 million. Lupron sales were down 4% to $193 million. Synthroid sales were flat at $188 million in the quarter....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters